Skip to content

Walking Alteration for Knee osteoarthritis, the WALK study. An RCT*

Walking Alteration for Knee osteoarthritis, the WALK study. An RCT* - WALK study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46305
Enrollment
144
Registered
2017-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arthrosis knee osteoarthritis

Interventions

Patients will be randomized in a) WALK gait retraining program or in b) physiotherapy with a standardised treatment protocol, in accordance with the Dutch guideline for physiotherapists on knee OA (
knee osteoarthritis
physical therapy
walk program

Sponsors

Maxima Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Symptomatic knee OA according to the clinical ACR criteria - Radiographic OA, according to Kellgren and Lawrence grade 1, 2 or 3 - Flexion contracture of 5 degrees or more, measured with a goniometer

Exclusion criteria

Exclusion criteria: - Medial or lateral instability of the knee, o Medial or lateral joint space opening of * 5 mm in 20° of knee flexion is considered as unstable. - Symptomatic bilateral knee OA - Intra-articular injection of the knee, in the previous 3 months - Previous peri-articular osteotomy of the affected knee - Symptomatic OA of hip or ankle - Co morbidity which disables the function of the lower extremity - Rheumatoid Arthritis or other inflammatory joint disease - Physical therapy for current complaints during last 3 months - Insufficient command of the Dutch language - Legally incompetent adults

Design outcomes

Primary

MeasureTime frame
Between group difference in change in pain / function score between baseline and 3 months follow-up.

Secondary

MeasureTime frame
Secondary outcomes are OMERACT*OARSI set of responder criteria, KOOS, NRS pain, EQ-5D, ICOAP, *need for TKA* OARSI-criteria, gait parameters as assessed by gait analyses (duration of full extension and quadriceps muscle activity during midstance of walking cycle) , and medication use. To get more insight in which specific patients will respond on the current intervention also the HADS, Central Sensitization Inventory, pain drawing form and pain cognition list will be evaluated.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)